The FDA has recently implemented a regulation that requires all women over 40 to receive information about their breast density along with their standard mammogram results. The FDA’s new rule ensures that the messages are now standardized.
Breast density refers to the amount of milk glands and connective tissue in the breast compared to fatty tissue. Having dense breasts makes it harder to detect cancer through a mammogram, and dense tissue is also considered a risk factor for developing breast cancer.
Mammogram studies show that about half of women over 40 are classified as having dense breasts.
Under the new rule, women with dense breasts will be encouraged to speak with their doctors about additional imaging tests, such as MRIs or ultrasounds, which may help detect cancers that might not show up on a mammogram.
However, some health experts are concerned that these notifications oversimplify a complex issue. Without clear, evidence-based guidance, many women might feel scared, confused, or frustrated.
Judith Garber, a senior policy analyst at the Lown Institute, points out that there’s no national standard for following up on dense breast reports, which could lead to inconsistent advice depending on a woman’s doctor.
Dr. Mark Pearlman, an emeritus professor at the University of Michigan Medical School, agrees. He explains that while some doctors may recommend additional tests, others might advise women to stick with regular mammograms.
Pearlman emphasises that a one-size-fits-all approach won’t work for all women with dense breasts.
A significant concern is that insurance companies do not always cover the costs of additional screening tests.
Robert Smith, an epidemiologist and senior vice president of cancer screening at the American Cancer Society, notes that while it’s important for women to know if they have dense breast tissue, it’s equally crucial to consider the affordability and accessibility of follow-up tests. Many women may not be able to afford the extra imaging, which could create disparities in who can take full advantage of the new rule.
Breast tissue is typically classified into four categories:
Extremely dense,
Mostly dense,
Mostly fatty, and
